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Previous research has shown that phosphate becomes depleted in the intestinal mucosa following local surgical 
injury or disease, triggering bacterial virulence and sepsis. Consequently, replenishment of depleted phosphate 
levels has been shown to prevent bacterial virulence in vitro[3] and sepsis in vivo[1]. Inverse phase miniemulsion 
polymerization (IPMP) has been extensively used in recent years in the production of nanocapsules for drug 
delivery of water-soluble therapeutic compounds that can be rendered degradable with time while allowing for 
sustained release of the encapsulated agent. In previous work we have successfully encapsulated inorganic 
phosphate salts, such as potassium monophosphate[2], into nanoparticles formed using IPMP. Our in vitro 
studies, however, have shown that polyphosphate salts, specifically sodium hexametaphosphate (PPi), are 
more effective at suppressing bacterial virulence[3]. This study focuses on the production and encapsulation of 
sodium hexametaphosphate into nanoparticles for controlled and extended release.  
 
Previous studies demonstrated[3] that encapsulation of sodium hexametaphosphate presents a series of 
challenges affecting the reproducibility of the IPMP process. Sodium hexametaphosphate is a strong lipophobe 
whose presence induces a high degree of order for water molecules. This modification in water structure 
weakens the surfactant interaction with water molecules, actively affecting the stability of the emulsion. This 
process, known as “salting-out”, has been shown to shift the hydrophilic-lipophilic balance (HLB) of nonionic 
surfactants towards a more lipophilic value[4]. While this issue has been addressed in a variety of previous 
studies, no mathematical correlation currently exists describing the effect of salt concentration on the HLB of a 
specific surfactant. Since miniemulsions require combinations of different phase-soluble surfactants, this adds to 
the complexity in predicting the extent and strength of the electrolyte effect on the stability of the emulsion 
system.  
 
In this study, we adjusted the IPMP process to counter the unstabilizing force created by the presence of 
sodium hexametaphosphate in the aqueous phase of the system. A precursor solution containing PEG 
diacrylate (PEGDA) macromer and NVP comonomer were chosen to create the hydrogel matrix, due to its 
biocompatibility and the ability to control the crosslinking density. The emulsion was formed of water in 
cyclohexane with the help of two nonionic surfactants, Tween 20 and SPAN 80. The effect of variations in HLB 
ranging from 4.0 to 9.5 on emulsion droplet size was investigated, for which the optimum overall HLB occurred 
at 6.5, an increase of two HLB points over the theoretical required value without salt interference[2, 3]. The effects 
of total surfactant amounts, reaction time, temperature and initiator concentration on nanoparticle yield were 
also explored. A final emulsion with 3.2% w/v of surfactants, 2 hours of reaction time, 64ºC and an initiator 
concentration equal to 1% of the initial double concentration resulted in a maximum nanoparticle mass yield of 
~39%. Finally, the particles were characterized in terms of crosslink density, showing an efficient encapsulation 
of the studied salt and a promising path for in-vivo testing. This study helped us develop a reproduceable 
formulation of an IPMP process that yields stable nanoparticles with suitable therapeutic levels of phosphates.  
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